| Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium JM Bryant, DM Grogono, D Rodriguez-Rincon, I Everall, KP Brown, ... Science 354 (6313), 751-757, 2016 | 532 | 2016 |
| Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities CJ Van Der Gast, AW Walker, FA Stressmann, GB Rogers, P Scott, ... The ISME journal 5 (5), 780-791, 2011 | 277 | 2011 |
| Low-dose nitric oxide as targeted anti-biofilm adjunctive therapy to treat chronic Pseudomonas aeruginosa infection in cystic fibrosis RP Howlin, K Cathie, L Hall-Stoodley, V Cornelius, C Duignan, RN Allan, ... Molecular Therapy 25 (9), 2104-2116, 2017 | 188 | 2017 |
| Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience FA Stressmann, GB Rogers, CJ Van Der Gast, P Marsh, LS Vermeer, ... Thorax 67 (10), 867-873, 2012 | 166 | 2012 |
| Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation? FA Stressmann, GB Rogers, P Marsh, AK Lilley, TWV Daniels, MP Carroll, ... Journal of Cystic Fibrosis 10 (5), 357-365, 2011 | 158 | 2011 |
| Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention L Cuthbertson, GB Rogers, AW Walker, A Oliver, LE Green, TWV Daniels, ... The ISME journal 10 (5), 1081-1091, 2016 | 111 | 2016 |
| Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections GB Rogers, FA Stressmann, G Koller, T Daniels, MP Carroll, KD Bruce Diagnostic microbiology and infectious disease 62 (2), 133-141, 2008 | 103 | 2008 |
| Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers FA Stressmann, GB Rogers, ER Klem, AK Lilley, SH Donaldson, ... Journal of clinical microbiology 49 (1), 281-291, 2011 | 87 | 2011 |
| Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy GB Rogers, LR Hoffman, M Whiteley, TWV Daniels, MP Carroll, KD Bruce Trends in microbiology 18 (8), 357-364, 2010 | 87 | 2010 |
| Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis TWV Daniels, GB Rogers, FA Stressmann, CJ Van Der Gast, KD Bruce, ... Journal of Cystic Fibrosis 12 (1), 22-28, 2013 | 70 | 2013 |
| Studying bacteria in respiratory specimens by using conventional and molecular microbiological approaches GB Rogers, TWV Daniels, A Tuck, MP Carroll, GJ Connett, GJP David, ... BMC pulmonary medicine 9, 1-11, 2009 | 65 | 2009 |
| Complexity, temporal stability, and clinical correlates of airway bacterial community composition in primary ciliary dyskinesia GB Rogers, MP Carroll, NMM Zain, KD Bruce, K Lock, W Walker, G Jones, ... Journal of Clinical Microbiology 51 (12), 4029-4035, 2013 | 59 | 2013 |
| Using explainable machine learning to characterise data drift and detect emergent health risks for emergency department admissions during COVID-19 C Duckworth, FP Chmiel, DK Burns, ZD Zlatev, NM White, TWV Daniels, ... Scientific reports 11 (1), 23017, 2021 | 55 | 2021 |
| Circulating biomarkers of antioxidant status and oxidative stress in people with cystic fibrosis: A systematic review and meta-analysis AJ Causer, JK Shute, MH Cummings, AI Shepherd, M Gruet, JT Costello, ... Redox biology 32, 101436, 2020 | 44 | 2020 |
| Cardiopulmonary exercise testing with supramaximal verification produces a safe and valid assessment of V̇o2max in people with cystic fibrosis: a retrospective … AJ Causer, JK Shute, MH Cummings, AI Shepherd, V Bright, G Connett, ... Journal of Applied Physiology 125 (4), 1277-1283, 2018 | 36 | 2018 |
| Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis KW Southern, C Castellani, E Lammertyn, A Smyth, D VanDevanter, ... Journal of Cystic Fibrosis 22 (1), 17-30, 2023 | 25 | 2023 |
| Real-World adherence among adults with cystic fibrosis is low: a retrospective analysis of the CFHealthHub digital learning health system ZH Hoo, N Totton, S Waterhouse, J Lewis, C Girling, M Bradburn, ... Chest 160 (6), 2061-2065, 2021 | 15 | 2021 |
| G385 RATNO–Reducing Antibiotic Tolerance using Nitric Oxide in Cystic Fibrosis: report of a proof of concept clinical trial K Cathie, R Howlin, M Carroll, S Clarke, G Connett, V Cornelius, ... Archives of disease in childhood 99 (Suppl 1), A159-A159, 2014 | 14 | 2014 |
| Using explainable machine learning to identify patients at risk of reattendance at discharge from emergency departments FP Chmiel, DK Burns, M Azor, F Borca, MJ Boniface, ZD Zlatev, NM White, ... Scientific reports 11 (1), 21513, 2021 | 13 | 2021 |
| The implications of dysglycaemia on aerobic exercise and ventilatory function in cystic fibrosis AJ Causer, JK Shute, MH Cummings, AI Shepherd, SR Wallbanks, ... Journal of Cystic Fibrosis 19 (3), 427-433, 2020 | 11 | 2020 |
